XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.0.1
License Agreements - Agenus (Details)
$ / shares in Units, $ in Thousands, shares in Millions
1 Months Ended 12 Months Ended 84 Months Ended
Feb. 01, 2017
USD ($)
$ / shares
shares
Jan. 31, 2015
item
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Dec. 31, 2021
USD ($)
License agreements            
Long term investments     $ 221,266 $ 222,301   $ 221,266
Unrealized gain (loss) on long term investments     (24,072) 10,426 $ 34,458  
Research and development expense     1,458,179 2,215,942 1,154,111  
Agenus            
License agreements            
Long term investments     $ 38,900 $ 44,700   $ 38,900
Shares divested (in shares) | shares     2.0 3.7    
Gross proceeds from sale of stock     $ 10,500 $ 17,200    
Ownership percentage (as a percent)     5.00%     5.00%
Unrealized gain (loss) on long term investments     $ 4,600 $ (10,300) $ 30,000  
Stock purchase agreement | Agenus            
License agreements            
Purchase of common stock under Stock Purchase Agreement (in shares ) | shares 10.0          
Purchase price of common stock $ 60,000          
Per share price | $ / shares $ 6.00          
Agenus            
License agreements            
Number of program targets | item   4        
Royalty payments on future global net sales (as a percent)     15.00%      
Milestone payment made under license agreement           $ 30,000
Agenus | Development, Regulatory and Commercialization Milestones            
License agreements            
Additional milestone payments under the license agreement     $ 500,000     $ 500,000
Agenus | Development, Regulatory and Commercialization Milestones | Minimum            
License agreements            
Royalty payments on future global net sales (as a percent)     6.00%      
Agenus | Development, Regulatory and Commercialization Milestones | Maximum            
License agreements            
Royalty payments on future global net sales (as a percent)     12.00%